About Saharshpharma
Saharshpharma is a Consumer company based in India. It offers branded formulations and baby care products through sales and marketing. It operates on a B2B and B2C model in Consumer and Healthcare sectors. Its Indian entity Saharsh Pharma Private Limited reported revenue of ₹28.1 Lakh. Saharshpharma offers products and services including CYNCAL-D3, FERZOME, ZELFIX-CV 625, MONTE-LEVO, and PARACYN-650. Its focus areas include Personal Care, Baby Products, Diapers and Wipes and Pharmaceuticals.
Company details
Saharsh Pharma, established in 2015 in Hyderabad, India, focuses on delivering quality and affordable healthcare solutions via branded formulations and baby care items. It operates through business models like contract development and its own supply chain, serving millions of consumers with products such as pharmaceuticals and personal care goods. The company emphasizes trust and relationships in the Indian market, aiming to make healthcare accessible.
- Headquarters India
- SectorsConsumerHealthcare
- Email••••••••
- Website saharshpharma.com
- Legal Name Saharsh Pharma Private Limited
- Date of Incorporation 19 Jul, 2023
- Jurisdiction Secunderabad, Telangana, India
- Annual Revenue₹28.1 Lakh
FY 2024
- Net Loss-₹34,395
FY 2024 · -1% margin
- EBITDA₹17,605
FY 2024 · 1% margin
Associated legal entities of Saharshpharma
Saharshpharma operates through Saharsh Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Saharsh Pharma Private Limited CIN U47721TS2023PTC175162 | Active | 19 Jul 2023 | Secunderabad, Telangana | ₹0.3 Cr | 2 | View details |
Products & Services of Saharshpharma
Saharshpharma offers a comprehensive portfolio of products and services, including CYNCAL-D3, FERZOME, ZELFIX-CV 625, MONTE-LEVO, and PARACYN-650.
Vitamin D supplement for health and bone maintenance purposes.
Iron supplement to support blood health and nutritional needs.
Antibiotic for treating bacterial infections effectively.
Medication for respiratory issues and allergy relief.
Pain reliever for fever and body ache management.
Antioxidant supplement for overall health benefits.
Wipes for baby cleaning and hygiene maintenance.
Absorbent diapers for infant comfort and dryness.
Gentle soap for baby skin cleansing and protection.
Moisturizing lotion for baby skin nourishment and care.
Board of directors of Saharsh Pharma Private Limited (Saharshpharma)
Saharsh Pharma Private Limited is the primary company behind Saharshpharma. The board of Saharsh Pharma Private Limited currently have 2 directors; the longest-serving is Sumalatha Guntupalli, appointed in 2023.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sumalatha Guntupalli DIN 08711025 | Director | 19 Jul 2023 | 3 yrs 3 mo | Saharsh Pharma Private Limited |
| Sailesh Sreeperumbuduru DIN 08713100 | Director | 19 Jul 2023 | 3 yrs 3 mo | Saharsh Pharma Private Limited |
Financials of Saharshpharma
Figures of Saharsh Pharma Private Limited, the primary company behind Saharshpharma, for FY 2024. Revenue was ₹28.1 Lakh. Net loss was -₹34,395 (-1% margin). EBITDA was ₹17,605 (1% margin).
- ₹28.1 LakhRevenue · FY 2024
- -₹34,395Net loss · -1% margin
- ₹17,605EBITDA · 1% margin
- ₹1.2 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Saharsh Pharma Private Limited are on its company page.
Detailed financial statements for Saharshpharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Saharshpharma
Saharshpharma is headquartered in India.
The primary company behind Saharshpharma, Saharsh Pharma Private Limited, reported revenue of ₹28.1 Lakh for FY 2024.
Saharsh Pharma, established in 2015 in Hyderabad, India, focuses on delivering quality and affordable healthcare solutions via branded formulations and baby care items. It operates through business models like contract development and its own supply chain, serving millions of consumers with products such as pharmaceuticals and personal care goods. The company emphasizes trust and relationships in the Indian market, aiming to make healthcare accessible.
Saharshpharma offers CYNCAL-D3, FERZOME, ZELFIX-CV 625, MONTE-LEVO, and 6 more products and services.
Saharshpharma operates through Saharsh Pharma Private Limited.
The legal entities of Saharshpharma currently have 2 directors, including Sumalatha Guntupalli, Sailesh Sreeperumbuduru.